Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Total Debt: 2011-2025

Historic Total Debt for Ani Pharmaceuticals (ANIP) over the last 10 years, with Sep 2025 value amounting to $312.9 million.

  • Ani Pharmaceuticals' Total Debt fell 2.23% to $312.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $312.9 million, marking a year-over-year decrease of 2.23%. This contributed to the annual value of $318.3 million for FY2024, which is 7.13% up from last year.
  • Ani Pharmaceuticals' Total Debt amounted to $312.9 million in Q3 2025, which was down 0.57% from $314.7 million recorded in Q2 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Total Debt peaked at $320.1 million during Q3 2024, and registered a low of $183.4 million during Q1 2021.
  • Over the past 3 years, Ani Pharmaceuticals' median Total Debt value was $310.3 million (recorded in 2023), while the average stood at $307.1 million.
  • In the last 5 years, Ani Pharmaceuticals' Total Debt decreased by 8.27% in 2021 and then skyrocketed by 56.55% in 2022.
  • Over the past 5 years, Ani Pharmaceuticals' Total Debt (Quarterly) stood at $287.4 million in 2021, then declined by 0.30% to $286.5 million in 2022, then climbed by 3.69% to $297.1 million in 2023, then climbed by 7.13% to $318.3 million in 2024, then dropped by 2.23% to $312.9 million in 2025.
  • Its Total Debt was $312.9 million in Q3 2025, compared to $314.7 million in Q2 2025 and $316.5 million in Q1 2025.